Overview

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Status:
Active, not recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of a protocol which does not suspend the new oral anticoagulants (dabigatran, rivaroxaban and apixaban) in front of dental extractions in patients with non-valvular atrial fibrillation.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Treatments:
Anticoagulants
Apixaban
Dabigatran
Rivaroxaban
Warfarin